收费全文 | 505篇 |
免费 | 163篇 |
国内免费 | 2篇 |
耳鼻咽喉 | 23篇 |
儿科学 | 29篇 |
妇产科学 | 8篇 |
基础医学 | 25篇 |
口腔科学 | 6篇 |
临床医学 | 65篇 |
内科学 | 64篇 |
皮肤病学 | 117篇 |
神经病学 | 23篇 |
特种医学 | 14篇 |
外科学 | 203篇 |
预防医学 | 5篇 |
眼科学 | 47篇 |
药学 | 2篇 |
肿瘤学 | 39篇 |
2024年 | 4篇 |
2023年 | 36篇 |
2022年 | 2篇 |
2021年 | 7篇 |
2020年 | 36篇 |
2019年 | 10篇 |
2018年 | 54篇 |
2017年 | 46篇 |
2016年 | 40篇 |
2015年 | 31篇 |
2014年 | 70篇 |
2013年 | 66篇 |
2012年 | 16篇 |
2011年 | 21篇 |
2010年 | 46篇 |
2009年 | 72篇 |
2008年 | 21篇 |
2007年 | 13篇 |
2006年 | 22篇 |
2005年 | 9篇 |
2004年 | 4篇 |
2003年 | 1篇 |
2002年 | 9篇 |
2001年 | 11篇 |
2000年 | 4篇 |
1999年 | 3篇 |
1998年 | 2篇 |
1997年 | 2篇 |
1996年 | 2篇 |
1994年 | 3篇 |
1992年 | 4篇 |
1991年 | 1篇 |
1990年 | 2篇 |
Method: A retrospective analysis of histopathology records of all the orbital tumours operated between 1993 and 2008 was undertaken at a tertiary care referral centre in northern India. The clinical, imaging and histopathological features of patients with cystic schwannoma were studied.
Results: A total of 600 specimens of orbital tumours were received during the study period. We found 39 cases of orbital schwannoma. Out of these, 16 (41%) had extensive cystic degeneration. The age of these patients ranged from 20 to 65 years. Eleven of the patients were female. Duration of symptoms varied from 3 months to 15 years. The most common clinical symptom was painless progressive proptosis with diminution of vision. The radiological picture was quite variable resulting in a primary diagnosis of combined venous-lymphatic vascular malformation in 2, lacrimal gland tumour in 2, dermoid cyst in 1, hydatid cyst in 2 and schwannoma in 5 cases.
Conclusion: Orbital schwannoma is a great masquerader in the orbit. Extensive cystic changes in schwannoma are uncommonly reported. Cystic schwannoma constituted 41% of all orbital schwannomas in our series. To the best of our knowledge, this is the largest case series of orbital cystic schwannomas. 相似文献
Methods: Halothane-anesthetized rats were fitted with instruments to measure CBF as determined by laser-Doppler flow (CBFldf) or to measure pial arteriolar diameter by preparing a cranial hollow deepened until a translucent plate of skull remained, thereby maintaining the integrity of the cranial vault. In both groups, 20 micro gram/kg dexmedetomidine was infused intravenously. Thirty minutes later, the mean arterial pressure was restored to control values with an infusion of phenylephrine (0.5 to 5 micro gram/kg/min).
Results: Administration of dexmedetomidine was associated with decreases in end-tidal and arterial carbon dioxide. The CBFldf and pial arteriolar diameter were measured during normocapnia (controlled carbon dioxide) and during dexmedetomidine-induced hypocapnia. Intravenous administration of dexmedetomidine significantly decreased systemic arterial pressure concurrent with a decrease in CBFldf (22% in normocapnic animals, 36% in hypocapnic animals). Restoration of mean arterial pressure increased CBFldf in normocapnic but not in hypocapnic animals. Similarly, dexmedetomidine significantly reduced pial vessel diameter in both normocapnic (9%) and hypocapnic animals (17%). However, vessel diameters remained decreased in the normocapnic and hypocapnic animals after the mean arterial pressure was restored. 相似文献